Utilization of Pharmacy Claims Data to Evaluate Therapeutic Interchange Programs

Utilization of Pharmacy Claims Data to Evaluate Therapeutic Interchange . Programs

SCOTT BULL, PHARM.D., is a Pharmacy Research Analyst, Kaiser Permanente Division of Research, Oakland, CA At the time of the study, he was Pharmacoeconomics/Outcomcs Research Fellow, Novartis Pharmaceuticals/Kaiser Permanente. OMAR SHOHEIBER, PHARMD., is Vice PresidcntPmduct Development, Tricore Technologies, North Brunswick, NJ At the time of the study, he was Associate Director, Outcomes Rese...

Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data

BACKGROUND Observational data are increasingly being used for pharmacoepidemiological, health services and clinical effectiveness research. Since pharmacies first introduced low-cost prescription programs (LCPP), researchers have worried that data about the medications provided through these programs might not be available in observational data derived from administrative sources, such as payer...

Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees

This is a review of key factors for pharmacy and therapeutics committees to consider when developing a therapeutic interchange (TI) program for venous thromboembolism (VTE) prophylaxis. Recent patient safety initiatives aimed at reducing the incidence of hospital-acquired VTE may increase the prescribing of thromboprophylactic agents recommended in VTE management guidelines. As a result, more p...

Project to Evaluate the Impact of Fountain House Programs on Medicaid Utilization and Expenditures

Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data.

PURPOSE Days supply (prescription duration) values are commonly used to estimate drug exposure and quantify adherence to therapy, yet accuracy is not routinely assessed, and potential inaccurate reporting has been previously identified. We examined the impact of cleaning days supply values on the measurement of adherence to oral bisphosphonates. METHODS We identified new users of oral bisphos...